Danaher Corporation (DHR) Stock Chart

NYSE
$217.79-6.90 (-3.07%)After hours

View the Danaher Corporation stock chart with market data, key statistics, volume, financial metrics, latest news, and exportable historical data.

Source
Yahoo Finance
Quote Time
Oct 14, 2026, 9:05 PM UTC
Delay
20 min source-reported delay

Market data is for research and educational use only, not investment advice. Quotes may be delayed depending on the source and exchange; verify important prices with your broker or data provider.

Read the DHR trend first

Use the range controls to compare short-term moves with the longer-term Danaher Corporation stock chart. A move that looks large on 1D can look routine on a 1Y or 5Y chart.

Check price with volume

Volume helps show whether a move happened with broad participation or thin trading. Compare recent bars with the average volume and news context before drawing conclusions.

Verify before acting

This page is built for research and education. Quotes, analyst fields, and news can be delayed or revised, so verify important prices with your broker or primary data provider.

Key Statistics

Previous Close$222.84
Open$225.00
Day Range$222.74 — $227.86
52 Wk Range$160.93 — $242.80
Volume3,595,463
Avg Volume4,774,525
Market Cap157.95B
P/E (TTM)40.05
P/E (Fwd)24.17
EPS (TTM)$5.61
Dividend Yield0.72%
Beta0.80
50 Day Avg$212.08
200 Day Avg$201.35
Shares Out702.99M
PEG Ratio1.33
Price/Book3.00

Financial Metrics

Revenue
25.11B
Revenue Growth
5.50%
Gross Margin
58.75%
Operating Margin
19.78%
Profit Margin
15.95%
Return on Equity
7.61%
Total Cash
4.35B
Total Debt
27.86B
Free Cash Flow
4.33B
Analyst Target
$244.14
Analyst Consensus
Strong Buy
Analyst Opinions
22

About Danaher Corporation

Sector
Healthcare
Industry
Diagnostics & Research
Employees
58,000
Headquarters
Washington, DC, United States
CEO
Mr. Steven M. Rales

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Related Charts

Data Definitions

Previous close

The most recent prior regular-session close reported by the market data source.

Day range

The source-reported high and low for the current or most recent trading session.

Volume

The number of shares, units, contracts, or asset quantity reported as traded during the period.

Moving averages

The 50-day and 200-day averages smooth recent prices to give quick trend context.

Market cap

A company or fund size estimate based on price and shares outstanding when source data is available.

P/E ratio

Price divided by earnings per share. It is most useful when compared with peers and growth expectations.